Zhen Teng Liu
Amministratore Delegato presso SHANDONG LUOXIN PHARMACY GROUP CO LTD
Patrimonio netto: 3 M $ in data 30/04/2024
Profilo
Zhen Teng Liu is currently the Chairman & General Manager at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
and Luoxin Pharmaceuticals Group Stock Co., Ltd.
He started his current positions in 2013 and 2020 respectively.
In terms of education, Mr. Liu holds an MBA from The University of New South Wales and an undergraduate degree from Macquarie University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/07/2023 | 4 689 648 ( 0.96% ) | 3 M $ | 30/04/2024 |
Posizioni attive di Zhen Teng Liu
| Società | Posizione | Inizio |
|---|---|---|
| SHANDONG LUOXIN PHARMACY GROUP CO LTD | Amministratore Delegato | 31/01/2023 |
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Amministratore Delegato | 23/04/2023 |
Formazione di Zhen Teng Liu
| Macquarie University | Undergraduate Degree |
| The University of New South Wales | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China. | Health Technology |
- Borsa valori
- Insiders
- Zhen Teng Liu